Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 7
1996 11
1997 8
1998 5
1999 7
2000 8
2001 13
2002 16
2003 10
2004 15
2005 8
2006 17
2007 19
2008 16
2009 21
2010 15
2011 21
2012 37
2013 37
2014 21
2015 29
2016 25
2017 18
2018 15
2019 8
2020 10
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

384 results
Results by year
Filters applied: . Clear all
Page 1
HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study.
Viscusi E, Minkowitz H, Winkle P, Ramamoorthy S, Hu J, Singla N. Viscusi E, et al. Hernia. 2019 Dec;23(6):1071-1080. doi: 10.1007/s10029-019-02023-6. Epub 2019 Aug 19. Hernia. 2019. PMID: 31429023 Free PMC article. Clinical Trial.
The purpose of the study was to assess the safety and efficacy of HTX-011 (bupivacaine and meloxicam in Biochronomer() polymer technology), a long-acting investigational anesthetic, in reducing both postoperative pain over 72 h and postoperative opioid use compared to bupi …
The purpose of the study was to assess the safety and efficacy of HTX-011 (bupivacaine and meloxicam in Biochronomer() polymer techno …
Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial.
Walton MB, Cowderoy EC, Wustefeld-Janssens B, Lascelles BD, Innes JF. Walton MB, et al. Vet Rec. 2014 Sep 20;175(11):280. doi: 10.1136/vr.102435. Epub 2014 May 23. Vet Rec. 2014. PMID: 24859353 Clinical Trial.
NSAIDs are the cornerstone of medical management of canine osteoarthritis (OA). Meloxicam is a daily-administered NSAID widely available in a liquid formulation and manufacturer's summary of product characteristics (SPC) advise that it is given at the lowest effective dose …
NSAIDs are the cornerstone of medical management of canine osteoarthritis (OA). Meloxicam is a daily-administered NSAID widely availa …
Analgesic Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-Severe Pain After Open Abdominal Hysterectomy: A Phase 2 Randomized Clinical Trial.
Rechberger T, Mack RJ, McCallum SW, Du W, Freyer A. Rechberger T, et al. Anesth Analg. 2019 Jun;128(6):1309-1318. doi: 10.1213/ANE.0000000000003920. Anesth Analg. 2019. PMID: 31094806 Free PMC article. Clinical Trial.
BACKGROUND: An intravenous (IV) formulation of meloxicam was developed for moderate-to-severe pain management. This study evaluated the safety and efficacy of meloxicam IV after open abdominal hysterectomy. Meloxicam IV is an investigational product not yet a …
BACKGROUND: An intravenous (IV) formulation of meloxicam was developed for moderate-to-severe pain management. This study evaluated t …
Preoperative intravenous meloxicam for moderate-to-severe pain in the immediate post-operative period: a Phase IIIb randomized clinical trial in 55 patients undergoing primary open or laparoscopic colorectal surgery with bowel resection and/or anastomosis.
Silinsky JD, Marcet JE, Anupindi VR, Karkare SU, Shah DR, Mack RJ, McCallum SW, Du W, Freyer A, Black LK. Silinsky JD, et al. Pain Manag. 2021 Jan;11(1):9-21. doi: 10.2217/pmt-2020-0061. Epub 2020 Oct 23. Pain Manag. 2021. PMID: 33094682 Free article. Clinical Trial.
Aim: Evaluate safety/efficacy of intravenous meloxicam in a colorectal enhanced recovery after surgery protocol. ...Conclusion: Meloxicam IV was generally well tolerated and associated with decreased opioid consumption, lower resource utilization and functional bene …
Aim: Evaluate safety/efficacy of intravenous meloxicam in a colorectal enhanced recovery after surgery protocol. ...Conclusion: Me
HTX-011 Reduced Pain and Opioid Use After Primary Total Knee Arthroplasty: Results of a Randomized Phase 2b Trial.
Lachiewicz PF, Lee GC, Pollak RA, Leiman DG, Hu J, Sah AP. Lachiewicz PF, et al. J Arthroplasty. 2020 Oct;35(10):2843-2851. doi: 10.1016/j.arth.2020.05.044. Epub 2020 May 27. J Arthroplasty. 2020. PMID: 32561266 Free article. Clinical Trial.
BACKGROUND: HTX-011 is an extended-release, dual-acting local anesthetic consisting of bupivacaine and low-dose meloxicam in a novel polymer that is administered by needle-free application during surgery. ...CONCLUSION: Needle-free application of HTX-011 400 mg bupivacaine …
BACKGROUND: HTX-011 is an extended-release, dual-acting local anesthetic consisting of bupivacaine and low-dose meloxicam in a novel …
[Clinical efficacy comparison between electroacupuncture and meloxicam in the treatment of knee os- teoarthritis at the early and middle stage: a randomized controlled trial].
Gang J, Mi Y, Wang H. Gang J, et al. Zhongguo Zhen Jiu. 2016 May;36(5):467-70. Zhongguo Zhen Jiu. 2016. PMID: 27509602 Clinical Trial. Chinese.
OBJECTIVE: To compare the clinical efficacy on knee osteoarthritis (KOA) at the early and middle stage between electroacupuncture (EA) and meloxicam. METHODS: Ninety patients of KOA at the early and middle stage were randomized into an EA group and a meloxicam group …
OBJECTIVE: To compare the clinical efficacy on knee osteoarthritis (KOA) at the early and middle stage between electroacupuncture (EA) and …
Evaluation of the efficacy of meloxicam for post-operative management of pain and inflammation in horses after orthopaedic surgery in a placebo controlled clinical field trial.
Walliser U, Fenner A, Mohren N, Keefe T, deVries F, Rundfeldt C. Walliser U, et al. BMC Vet Res. 2015 May 15;11:113. doi: 10.1186/s12917-015-0427-4. BMC Vet Res. 2015. PMID: 25976845 Free PMC article. Clinical Trial.
Recently the utility of post-operative pain management was emphasized. It was therefore our aim to determine the efficacy of meloxicam in horses following partial resection of fractured splint bones. ...RESULTS: Sixty-six client owned horses requiring unilateral partial sp …
Recently the utility of post-operative pain management was emphasized. It was therefore our aim to determine the efficacy of meloxicam
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.
Berkowitz RD, Steinfeld R, Sah AP, Mack RJ, McCallum SW, Du W, Black LK, Freyer A, Coyle E. Berkowitz RD, et al. Pain Med. 2021 Jun 4;22(6):1261-1271. doi: 10.1093/pm/pnab016. Pain Med. 2021. PMID: 33502533 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate the effect of perioperative meloxicam IV 30 mg on opioid consumption in primary total knee arthroplasty (TKA). ...SUBJECTS: In total, 181 adults undergoing elective primary TKA. METHODS: Subjects received meloxicam 30 mg or placebo via an IV b …
OBJECTIVE: To evaluate the effect of perioperative meloxicam IV 30 mg on opioid consumption in primary total knee arthroplasty (TKA). …
Meloxicam for intravenous use: review of its clinical efficacy and safety for management of postoperative pain.
Berkowitz RD, Mack RJ, McCallum SW. Berkowitz RD, et al. Pain Manag. 2021 May;11(3):249-258. doi: 10.2217/pmt-2020-0082. Epub 2020 Dec 9. Pain Manag. 2021. PMID: 33291975 Free article. Clinical Trial.
Meloxicam for intravenous use (meloxicam iv.) is a nanocrystal formulation with improved dissolution properties and shortened time to peak plasma concentrations versus oral meloxicam. ...In Phase III trials, it demonstrated adverse event profile similar to pl
Meloxicam for intravenous use (meloxicam iv.) is a nanocrystal formulation with improved dissolution properties and shortened
Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
Gruet P, Seewald W, King JN. Gruet P, et al. BMC Vet Res. 2013 May 2;9:92. doi: 10.1186/1746-6148-9-92. BMC Vet Res. 2013. PMID: 23638669 Free PMC article. Clinical Trial.
A total of 174 dogs undergoing major soft tissue surgery were included and randomly allocated in a 2:1 ratio to receive either robenacoxib (n = 118) or the positive control, meloxicam (n = 56). Each dog received an initial dose subcutaneously prior to surgery (robenacoxib …
A total of 174 dogs undergoing major soft tissue surgery were included and randomly allocated in a 2:1 ratio to receive either robenacoxib ( …
384 results